Brief: FinnGen Selects Azenta To Propel Personalized Medicine For Population Health Study
July 22 (Reuters) - Azenta Inc AZTA.O :
* FINNGEN SELECTS AZENTA TO PROPEL PERSONALIZED MEDICINE FOR
POPULATION HEALTH STUDY
Source text for Eikon: ID:nPn1c5qvWa
Further company coverage: AZTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Azenta
See all newsUS RESEARCH ROUNDUP-Adobe, Domino's Pizza, Goldman Sachs
Brief: Azenta - Approves Restructuring Plan Within Multiomics Segment On October 5, 2026
Brooks Automation confidentially files for US IPO (updated)
U.S. STOCKS ON THE MOVE-Azenta, Qiagen NV, Capricor Therapeutics
Azenta names interim CEO after Marotta resigns; shares fall